Administration of dexamethasone protects mice against ischemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2366-2375

  Zhang, Jiong ^a   Yao, Ying ^a   Xiao, Fang ^a   Lan, Xiaoqin ^a   Yu, Chong ^a   Zhang, Ying ^a   Jiang, Cao ^a   Yang, Juan ^a   Pei, Guangchang ^a   Li, Yueqiang ^a   Rong, Song ^b   Hu, Shuang ^a   Li, Junhua ^a   Xu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Dexamethasone; Glucocorticoid receptor; Inflammatory response; Ischemia reperfusion injury; PI3K AKT signaling

Indexed keywords

AUTACOID; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; C57BL MOUSE; CELL PROTECTION; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; ISCHEMIA/REPERFUSION INJURY; KIDNEY; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PI3K/AKT SIGNALING; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASCULARIZATION;

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INFLAMMATORY RESPONSE; ISCHEMIA/REPERFUSION INJURY; PI3K/AKT SIGNALING;

ACUTE KIDNEY INJURY; ANIMALS; CYTOKINES; CYTOPROTECTION; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; INFLAMMATION MEDIATORS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, GLUCOCORTICOID; REPERFUSION INJURY; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84887113748     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aydin Z, van Zonneveld AJ, de Fijter JW and Rabelink TJ. New horizons in prevention and treatment of ischaemic injury to kidney transplants. Nephrol Dial Transplant 2007;22:342-346.
2. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A and Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
3. Kazmers A, Jacobs L and Perkins A. The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res 1997;67:62-66.
4. Levy EM, Viscoli CM and Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-1494.
5. Schiffl H, Lang SM and Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-310.
6. Chertow GM, Burdick E, Honour M, Bonventre JV and Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-3370.
7. Kusch A, Hoff U, Bubalo G, Zhu Y, Fechner M, Schmidt-Ullrich R, Marko L, Muller DN, Schmidt-Ott KM, Gurgen D, Blum M, Schunck WH and Dragun D. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiol (Oxf) 2013;208:25-40.
8. Fan LH, He L, Cao ZQ, Xiang B and Liu L. Effect of ischemia preconditioning on renal ischemia/ reperfusion injury in rats. Int Braz J Urol 2012;38:842-854.
9. Amura CR, Renner B, Lyubchenko T, Faubel S, Simonian PL and Thurman JM. Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol 2012;52:249-257.
10. Fry MJ. Structure, regulation and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1994;1226:237-268.
11. Ravingerova T, Carnicka S, Nemcekova M, Ledvenyiova V, Adameova A, Kelly T, Barlaka E, Galatou E, Khandelwal VK and Lazou A. PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury:involvement of PI3K-Akt. Can J Physiol Pharmacol 2012;90:1135-1144.
12. Sano T, Izuishi K, Hossain MA, Kakinoki K, Okano K, Masaki T and Suzuki Y. Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury. HPB (Oxford) 2010;12:538-545.
13. Bagchi P, Nandi S, Nayak MK and Chawla-Sarkar M. Molecular mechanism behind rotavirus NSP1-mediated PI3 kinase activation:interaction between NSP1 and the p85 subunit of PI3 kinase. J Virol 2013;87:2358-2362.
14. Perdiguero E, Sousa-Victor P, Ruiz-Bonilla V, Jardi M, Caelles C, Serrano AL and Munoz-Canoves P. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. J Cell Biol 2011;195:307-322.
15. Xie L, Zheng X, Qin J, Chen Z, Jin Y and Ding W. Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice. Nephrology (Carlton) 2006;11:207-212.
16. Baker RC, Armstrong MA, Young IS, McClean E, O'Rourke D, Campbell FC, D'Sa AA and McBride WT. Methylprednisolone increases urinary nitrate concentrations and reduces subclinical renal injury during infrarenal aortic ischemia reperfusion. Ann Surg 2006;244:821-826.
17. Odermatt A and Kratschmar DV. Tissue-specific modulation of mineralocorticoid receptor function by 11beta-hydroxysteroid dehydrogenases: an overview. Mol Cell Endocrinol 2012;350:168-186.
18. Zheng Y, Xiong S, Jiang P, Liu R, Liu X, Qian J, Zheng X and Chu Y. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155:a novel anti-inflammation mechanism. Free Radic Biol Med 2012;52:1307-1317.
19. Pulitano C and Aldrighetti L. The protective role of steroids in ischemia-reperfusion injury of the liver. Curr Pharm Des 2008;14:496-503.
20. Spanier AJ and McDonough KH. Dexamethasone blocks sepsis-induced protection of the heart from ischemia reperfusion injury. Proc Soc Exp Biol Med 2000;223:82-87.
21. Kumar S, Allen DA, Kieswich JE, Patel NS, Harwood S, Mazzon E, Cuzzocrea S, Raftery MJ, Thiemermann C and Yaqoob MM. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol 2009;20:2412-2425.
22. Fang J, He L, Wang SQ, Ma MJ, Liu HY, Zhu XH, Zhu P, Wei X and Wang CY. A simplified two-stitch sleeve technique for arterial anastomosis of cervical heterotopic cardiac transplantation in mice. Am J Transl Res 2013;5:521-529.
23. Zheng X, Feng B, Chen G, Zhang X, Li M, Sun H, Liu W, Vladau C, Liu R, Jevnikar AM, Garcia B, Zhong R and Min WP. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 2006;6:2099-2108.
24. Yang P, Zhang Y, Pang J, Zhang S, Yu Q, He L, Wagner KU, Zhou Z and Wang CY. Loss of Jak2 Impairs Endothelial Function by Attenuating Raf-1/MEK1/Sp-1 Signaling Along with Altered eNOS Activities. Am J Pathol 2013;183:617-625.
25. Zhang S, Lv JW, Yang P, Yu Q, Pang J, Wang Z, Guo H, Liu S, Hu J, Li J, Leng J, Huang Y, Ye Z and Wang CY. Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol 2012;181:937-946.
26. Li S, Gokden N, Okusa MD, Bhatt R and Portilla D. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol 2005;289:F469-480.
27. Li J, Gong Q, Zhong S, Wang L, Guo H, Xiang Y, Ichim TE, Wang CY, Chen S, Gong F and Chen G. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant 2011;26:469-478.
28. Okkenhaug K and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 2003;3:317-330.
29. Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003;4:313-319.